J Neurol Surg A Cent Eur Neurosurg 2020; 81(04): 348-354
DOI: 10.1055/s-0040-1709163
Technical Note
Georg Thieme Verlag KG Stuttgart · New York

Combined Surgical Resection and Laser Interstitial Thermal Therapy for Glioblastoma: Technical Note

Rafael A. Vega
1   Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, Texas, United States
,
Jeffrey I. Traylor
1   Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, Texas, United States
,
Rajan Patel
1   Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, Texas, United States
,
Matthew Muir
1   Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, Texas, United States
,
Dheigo C.A. Bastos
1   Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, Texas, United States
,
Sujit S. Prabhu
1   Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, Texas, United States
› Author Affiliations
Further Information

Publication History

29 April 2019

06 August 2019

Publication Date:
03 May 2020 (online)

Abstract

Background Glioblastoma multiforme (GBM) is an aggressive intracranial malignancy that confers a poor prognosis despite maximum surgical resection and chemoradiotherapy. Survival decreases further with deep-seated lesions. Laser interstitial thermal therapy (LITT) is an emerging minimally invasive technique for tumor ablation shown to reduce tumor burden effectively, particularly in deep-seated locations less amenable to gross total resection. We describe our initial technical experience of using the combination of LITT followed by surgical resection in patients with GBMs that exhibit both an easily accessible and deep-seated component.

Materials and Methods Patients with GBM who received concurrent LITT and surgical resection at our institution were identified. Patient demographic and clinical information was procured from the University of Texas MD Anderson Cancer Center electronic medical record along with preoperative, postoperative, and 1-month follow-up magnetic resonance imaging (MRI).

Results Four patients (n = 2 male, n = 2 female) with IDH-wild type GBM who received combined LITT and surgical resection were identified and analyzed retrospectively. All patients received chemoradiotherapy before presentation. All but one patient (75%) received resection before presentation. Median age was 54 years (range: 44–56 years). Median length of hospital stay was 6.5 days (range: 2–47 days). Median extent of combined ablation/resection was 90.4%. One of the four patients experienced complications in the perioperative or immediate follow-up periods. Local recurrence was observed in one patient during the follow-up period.

Conclusion Malignant gliomas in deep-seated locations or in close proximity to white matter structures are challenging to manage. LITT followed by surgical resection may provide an alternative for tumor debulking that minimizes potential morbidities and extent of residual tumor. Further studies comparing this approach with standard resection techniques are warranted.

 
  • References

  • 1 Ostrom QT, Bauchet L, Davis FG. , et al. The epidemiology of glioma in adults: a “state of the science” review. Neuro Oncol 2014; 16 (07) 896-913
  • 2 Stupp R, Mason WP, van den Bent MJ. , et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352 (10) 987-996
  • 3 Brown TJ, Brennan MC, Li M. , et al. Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol 2016; 2 (11) 1460-1469
  • 4 Quick J, Gessler F, Dützmann S. , et al. Benefit of tumor resection for recurrent glioblastoma. J Neurooncol 2014; 117 (02) 365-372
  • 5 Vogelbaum MA. The benefit of surgical resection in recurrent glioblastoma. Neuro Oncol 2016; 18 (04) 462-463
  • 6 Pessina F, Navarria P, Cozzi L. , et al. Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. J Neurooncol 2017; 131 (02) 377-384
  • 7 Noorbakhsh A, Tang JA, Marcus LP. , et al. Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis. J Neurosurg 2014; 120 (01) 31-39
  • 8 Hori T, Ishida A, Aihara Y, Matsuo S, Yoshimoto H, Shiramizu H. Surgery of critically located intracranial gliomas. Prog Neurol Surg 2018; 30: 186-203
  • 9 De Poorter J. Noninvasive MRI thermometry with the proton resonance frequency method: study of susceptibility effects. Magn Reson Med 1995; 34 (03) 359-367
  • 10 Missios S, Bekelis K, Barnett GH. Renaissance of laser interstitial thermal ablation. Neurosurg Focus 2015; 38 (03) E13
  • 11 Schwarzmaier HJ, Eickmeyer F, von Tempelhoff W. , et al. MR-guided laser-induced interstitial thermotherapy of recurrent glioblastoma multiforme: preliminary results in 16 patients. Eur J Radiol 2006; 59 (02) 208-215
  • 12 Carpentier A, Chauvet D, Reina V. , et al. MR-guided laser-induced thermal therapy (LITT) for recurrent glioblastomas. Lasers Surg Med 2012; 44 (05) 361-368
  • 13 Sloan AE, Ahluwalia MS, Valerio-Pascua J. , et al. Results of the NeuroBlate System first-in-humans phase I clinical trial for recurrent glioblastoma: clinical article. J Neurosurg 2013; 118 (06) 1202-1219
  • 14 Shah A, Burks J, Buttrick S. , et al. Laser interstitial thermal therapy as a primary treatment for deep inaccessible gliomas. Neurosurgery 2019; 84 (03) 768-777
  • 15 Hawasli AH, Bagade S, Shimony JS, Miller-Thomas M, Leuthardt EC. Magnetic resonance imaging-guided focused laser interstitial thermal therapy for intracranial lesions: single-institution series. Neurosurgery 2013; 73 (06) 1007-1017
  • 16 Jethwa PR, Barrese JC, Gowda A, Shetty A, Danish SF. Magnetic resonance thermometry-guided laser-induced thermal therapy for intracranial neoplasms: initial experience. Neurosurgery 2012; 71 (1, Suppl Operative): 133-144 , 144–145
  • 17 Thomas JG, Rao G, Kew Y, Prabhu SS. Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma. Neurosurg Focus 2016; 41 (04) E12
  • 18 Mohammadi AM, Hawasli AH, Rodriguez A. , et al. The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-to-access high-grade gliomas: a multicenter study. Cancer Med 2014; 3 (04) 971-979
  • 19 Pisipati S, Smith KA, Shah K, Ebersole K, Chamoun RB, Camarata PJ. Intracerebral laser interstitial thermal therapy followed by tumor resection to minimize cerebral edema. Neurosurg Focus 2016; 41 (04) E13
  • 20 Sharma M, Balasubramanian S, Silva D, Barnett GH, Mohammadi AM. Laser interstitial thermal therapy in the management of brain metastasis and radiation necrosis after radiosurgery: an overview. Expert Rev Neurother 2016; 16 (02) 223-232
  • 21 Schroeder JL, Missios S, Barnett GH. , et al. Laser interstitial thermal therapy as a novel treatment modality for brain tumors in the thalamus and basal ganglia. Photonics Lasers Med 2014; 3 (02) 151-158
  • 22 Lacroix M, Abi-Said D, Fourney DR. , et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001; 95 (02) 190-198
  • 23 Li YM, Suki D, Hess K, Sawaya R. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: can we do better than gross-total resection?. J Neurosurg 2016; 124 (04) 977-988
  • 24 Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 2011; 115 (01) 3-8
  • 25 Stummer W, Reulen HJ, Meinel T. , et al; ALA-Glioma Study Group. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 2008; 62 (03) 564-576 ; discussion 564–576
  • 26 Oppenlander ME, Wolf AB, Snyder LA. , et al. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity. J Neurosurg 2014; 120 (04) 846-853
  • 27 Laws ER, Parney IF, Huang W. , et al; Glioma Outcomes Investigators. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 2003; 99 (03) 467-473
  • 28 Ivan ME, Mohammadi AM, De Deugd N. , et al. Laser ablation of newly diagnosed malignant gliomas: a meta-analysis. Neurosurgery 2016; 79 (Suppl. 01) S17-S23
  • 29 Chaichana KL, Zadnik P, Weingart JD. , et al. Multiple resections for patients with glioblastoma: prolonging survival. J Neurosurg 2013; 118 (04) 812-820
  • 30 Perrini P, Gambacciani C, Weiss A. , et al. Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis. J Neurooncol 2017; 131 (03) 585-591
  • 31 Sughrue ME, Sheean T, Bonney PA, Maurer AJ, Teo C. Aggressive repeat surgery for focally recurrent primary glioblastoma: outcomes and theoretical framework. Neurosurg Focus 2015; 38 (03) E11
  • 32 Wright J, Chugh J, Wright CH. , et al. Laser interstitial thermal therapy followed by minimal-access transsulcal resection for the treatment of large and difficult to access brain tumors. Neurosurg Focus 2016; 41 (04) E14
  • 33 Maraka S, Asmaro K, Walbert T, Lee I. Cerebral edema induced by laser interstitial thermal therapy and radiotherapy in close succession in patients with brain tumor. Lasers Surg Med 2018; 50 (09) 917-923